Cargando…
The emergence of AntibodyPlus: the future trend of antibody-based therapeutics
To date, close to 100 canonical monoclonal antibody drugs have been approved by the FDA; furthermore, a number of antibody-derived therapeutics in nontraditional formats have reached late development stages and the market, and many more are being evaluated in early-stage development. To better refle...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590318/ https://www.ncbi.nlm.nih.gov/pubmed/36299417 http://dx.doi.org/10.1093/abt/tbac024 |